GlassScriptPhysician profile
Amy L Head
NPI 1124419031
$1,744.74
in general payments reported to CMS, 2019-2025
21 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $490 · 2022: $494 · 2023: $216 · 2024: $238 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.19 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $217.00 | 2025 | Stratafix |
| Astrazeneca Pharmaceuticals LP | $203.25 | 2022 | |
| Janssen Pharmaceuticals, INC | $156.74 | 2021-2024 | Xarelto |
| Bioventus LLC | $153.50 | 2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Ucb, INC. | $151.64 | 2022-2024 | Briviact, Nayzilam |
| Novartis Pharmaceuticals Corporation | $133.44 | 2021-2024 | |
| Ipsen Biopharmaceuticals, INC | $124.96 | 2021 | |
| Coherus Oncology, INC. | $121.85 | 2021 | |
| Pharmacosmos Therapeutics INC. | $97.22 | 2022 | |
| Pfizer INC. | $95.93 | 2021-2023 | |
| Seagen INC. | $82.55 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $51.23 | 2025 | |
| Advanced Respiratory, INC | $26.67 | 2021 | |
| Ethicon US, LLC | $21.40 | 2025 | Vistaseal |
| Pacira Pharmaceuticals Incorporated | $16.43 | 2025 | Zilretta |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.38 | 2022 | |
| Boston Scientific Corporation | $15.96 | 2024 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $15.28 | 2022 | |
| Bard Peripheral Vascular, INC. | $14.91 | 2021 | |
| Mallinckrodt Hospital Products INC. | $14.61 | 2024 | Terlivaz |
| Avanir Pharmaceuticals, INC. | $13.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Head listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.